...As Shalina Celebrates 40 Years of Commitment to Quality Healthcare
In a significant partnership aimed at enhancing access to quality pain relief, the Pharmaceutical Society of Nigeria (PSN) has signed a Memorandum of Understanding (MOU) with Shalina Healthcare to endorse IBUCAP capsule, a flagship pain relief medication.
The endorsement was formalised at the opening ceremony of the 97th PSN Annual National Conference, held at Ibom Hall, Uyo.
Speaking on behalf of Shalina Healthcare, Pharm. Chief Emeka Adimoha, pharma director and regulatory head, expressed gratitude for the endorsement, highlighting IBUCAP’s effectiveness and longevity as a trusted painkiller.
“This MOU signifies PSN’s endorsement of IBUCAP as a high-quality painkiller,” he stated. “For over 20 years, IBUCAP capsule has proven its value in Nigeria, and with PSN’s support, we look forward to continuing to provide Nigerians with reliable and affordable medication options.” Adimoha noted that Shalina’s ongoing expansion efforts aim to increase production capacity and foster greater local impact.
Reflecting on the company’s milestone of 40 years in the healthcare sector, Adimoha added, “This endorsement is particularly meaningful as we celebrate four decades of commitment at Shalina and twenty years of trust in IBUCAP capsule. I feel both elated and motivated to continue our work in supporting Nigeria’s healthcare needs.”
In response to the MOU, PSN President Prof. Cyril Usifoh commended Shalina Healthcare’s commitment to quality, saying the PSN’s endorsement of IBUCAP capsule is not just a recognition of its efficacy as a triple-action pain reliever but also a testament to Shalina’s dedication to making quality drugs accessible to Nigerians.
Prof. Usifoh emphasised PSN’s mission to endorse products that meet rigorous standards and bring value to the healthcare sector. “With this partnership, we are aligning with Shalina in their mission to deliver effective and affordable solutions for pain management to the public.”
Shalina’s Marketing Manager, Mr Chiuba Nwaosu, expressed excitement over the endorsement, noting it as an affirmation of Shalina’s vision to lead in providing quality medications across Africa.
“Our partnership with PSN strengthens our resolve to set higher standards and extend our reach,” Nwaosu remarked. He added that Shalina’s recent investments in a manufacturing facility in Nigeria, which employs over 120 local staff, reflects the company’s commitment to localised, sustainable production.
Beyond IBUCAP capsule, Nwaosu highlighted Shalina’s additional contributions to the healthcare sector, including the SYTA Youth Talent Award programme for pharmacy students across Nigerian universities and the Flying Stars initiative in collaboration with doctors.
He noted that the partnership with PSN further solidifies Shalina’s role in the health sector as both a trusted provider and a supporter of educational and professional development within pharmacy.
The event underscored the joint ambition of both PSN and Shalina to enhance access to effective and affordable healthcare for Nigerians.
){kind=link}